CDK7 and head and neck squamous cell carcinoma: Notably, a shift in CDK7 electrophoretic mobility was detected upon treatment with YKL-5-124 in all HNSCC, likely due to the covalent binding of this compound (Fig. 3d and Supplementary Fig. 3c–f).